研究目的
Investigating the development and application of a deep-red fluorogenic probe for rapid detection of nitric oxide in Parkinson’s disease models.
研究成果
The deep-red fluorogenic probe BT-NH demonstrated high sensitivity and good selectivity for NO detection in both cellular and Drosophila PD models. Its ability to visualize NO levels in living cells and tissues makes it a promising tool for studying NO-related diseases, including PD.
研究不足
The study did not explore the probe's application in human PD models or its potential side effects in vivo. The sensitivity and selectivity were tested in controlled environments, which may differ in more complex biological systems.
1:Experimental Design and Method Selection:
The study involved the design and synthesis of a deep-red fluorogenic probe (BT-NH) for NO detection, utilizing a benzo-bis(1,2,5-thiadiazol) fluorophore. The probe's sensitivity and selectivity to NO were evaluated through absorption and fluorescence spectra.
2:Sample Selection and Data Sources:
HepG2, SH-SY5Y, and 293T cells were used for in vitro studies, and Parkin null Drosophila were used as a PD model for in vivo studies.
3:List of Experimental Equipment and Materials:
Instruments included a Bruker Ultra Shield Plus for NMR, Synergy HTX microplate reader for absorption spectra, and Cytation 5 microplate reader for photoluminescence spectra. Confocal laser scanning microscopy (CLSM) was used for imaging.
4:Experimental Procedures and Operational Workflow:
Cells were treated with NO donors or inhibitors, incubated with BT-NH, and then imaged. Drosophila brains were dissected, incubated with BT-NH, and imaged.
5:Data Analysis Methods:
Fluorescence intensity was quantified to assess NO levels, with statistical analysis performed to determine sensitivity and selectivity.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容